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Abstract
Many proteins express multiple allosterically regulated conformational
states, with protein function regulated by effector molecules, environmental responses
and other ligands. One such protein is the LFA-1 surface integrin protein and its
inserted domain, the I-domain. We Isolated the I-domain for investigation of
determining binding properties and understanding conformational regulations of affinity
changes to its target ligand ICAM-1, for further use in chimeric protein switch design. A
large change in binding affinity was found through the disruption of a sub-sequence of
amino acids in I-domain known as the α7 helix. When the α7 helix is deleted, I-domain
converts into a permanent high affinity state in which binding affinity to ICAM-1 was
increased. (This state can be reversed by co-expression with soluble α7 helix peptide.)
These results conclude that the α7 helix stabilizes the I domain in its low affinity
conformation in a ligand-like manner, allowing relaxation to the high affinity
conformation upon disruption of α7 helix interaction. α7 helix deletion I-domain can not
be applied in design of chimeric protein switches due to its permanent conformational
state. Switch design has a focus of allosterically regulating the I-domain and α7 helix
through utilizing on/off switching of conformational states. I-domain is fused with EF3
and EF4 hands of calmodulin, which then regulates binding affinity to ICAM-1 through
interaction with α7 helix, when the EF hands’ natural ligand peptides are present.
Mutant switches are being developed to alter EF hand binding specificity which, when
bound to target ligand, will cause an increase in I-domain-ICAM-1 binding affinity in
switch molecules. The results of these allosteric regulations highlight the potential of
chimeric protein switches for design of environmentally responsive targeting agents
and suggest that, through directed evolution, regulated binding to a range of novel
targets could be achieved for therapeutic intervention.

Introduction

Main Method Used

Switch I-domain surface-displayed

Boder, E. T.; Wittrup, K. D., Yeast surface display for directed evolution of protein expression, affinity, and stability. Meth Enzymol 2000,
328, 430-44.

Yeast surface display was utilized to detect presence of expressed I-domain and
binding of ICAM-1 using fluorescent tags.

α7 helix-deleted I-domain
Design two experiments to explore the I domain affinity alteration:
1. Design an I-domain without α7 helix (Δα7 I domain)
2. Design an experiment to make Δα7 I domain bind with different peptides.

Δα7

Image shows the conformational regulation of the chimeric protein switch when the EF
hands are bound to their natural ligand, smMLCK. Yeast surface display data showing the
detection of I-domain and EF hands of chimeric protein switches binding to target ligands.

Regulated Conformational States

α7

• I-domain of integrin LFA-1 mediates leukocyte adhesion to the endothelium by
interaction with ICAM-1, upregulated at sites of inflammation.
• “Bell rope” model for the conformation change within I domain suggests that force
applied to the α7 helix of I domain is transduced to causes structure rearrangement
leading to activation.
• Understanding conformational regulation of I-domain in switch design, will further
the creation of efficient environmentally responsive targeting agents. Also, giving us
further insight into possible regulated binding to a range of new novel targets.
.

When the EF hands are bound to their natural target ligand (smMLCK) it creates a
allosterically regulated structural rearrangement throughout the chimeric protein switch.

Soluble I-domain Dynamic Data

Mutant Switch Screening
Through mutagenesis and directed evolution, we are engineering new switch mutants with
mutated EF hands to alter peptide binding specificity. The purpose of which is to:
1. Engineer EF hands that bind to a new target ligand that will cause an increase in I-domainICAM-1 binding affinity in switch molecules.
2. Determine changes in I-domain binding affinity when EF hands are bound to new ligands.
3. Improve environmental response to new ligands in chimeric switch design.
We currently are screening engineered switch molecules with mutated EF hands for the purpose
of increasing I-domain binding affinity through altered disruptions of the α7 helix. This also
demonstrates the possibility of, through directed evolution, regulated binding to a range of new
novel targets.

Conclusions

The main purpose of this research:
1. Explore the interaction of the α7 helix with the rest of the I domain to
determine the mechanism of affinity regulation.
2. Develop a new chimeric I domain protein with improved affinity regulation
through use of EF hand mutants bound to new novel target ligands.
3. Investigate the design of generic molecules with designable environmental
triggers through directed evolution.

• Disruption of the α7 helix region of I-domain induces the high affinity conformation.
• A chimeric protein incorporating the EF hand domains from calmodulin disrupts the
α7 helix in response to EF hand-binding peptide ligands.
• Alteration of peptide binding specificity data in EF hand mutants shows an increase
in binding affinity in I-domain when bound to new peptides.
* Moonsoo Jin, Gang Song, Christopher Carman, et al. Directed evolution to probe protein allostery and integrin I domains of 200,000fold higher affinity. PNAS 2006,103,5758-5763

The Surface Plasmon resonance (SPR,Biacore 3000) data shows that soluble ∆α7 I
domain has similar affinity to an I-domain mutant locked into the high affinity conformation
by an engineered disulfide bond.
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